Autoimmune Bullous Disorders induced by Cyclin-Dependent Kinase 4/6 inhibitors – first case series from the EADV Task Force “Dermatology for Cancer Patients”

• A. Ortiz Brugués,
• P. Sollena,
• M. Starace,
• F. Bardazzi,
• D. Koumaki,
• Z. Apalla,
• M. Iorizzo,
• C. Bost,
• S. Milesi,
• J.L. Lacaze,
• K. Peris,
• V. Sibaud

Affiliations

A. Ortiz Brugués

Institut Universitaire du Cancer - Oncopole, Toulouse, France

P. Sollena

Fondazione Policlinico Universitario, Rome, Italy

M. Starace

Ospedale sant'Orsola-Malpighi, Bologna, Italy

F. Bardazzi

Ospedale sant'Orsola-Malpighi, Bologna, Italy

D. Koumaki

University Hospital of Heraklion, Heraklion, Greece

Z. Apalla

Aristotle University of Thessaloniki, Thessaloniki, Greece

M. Iorizzo

Private Dermatology Practice, Lugano/Bellinzona, Switzerland

C. Bost

Centre Hospitalier Universitaire, Toulouse, France

S. Milesi

Institut Universitaire du Cancer - Oncopole, Toulouse, France

J.L. Lacaze

Institut Universitaire du Cancer - Oncopole, Toulouse, France

K. Peris

Fondazione Policlinico Universitario ''Agostino Gemelli'', Rome, Italy

V. Sibaud

Institut Universitaire du Cancer - Oncopole, Toulouse, France